Real-World Effectiveness of Nirmatrelvir-Ritonavir and Its Acceptability in High-Risk COVID-19 Patients

BACKGROUND: Nirmatrelvir-ritonavir is highly effective in preventing severe coronavirus disease 2019 (COVID-19) in high-risk patients with mild-to-moderate severity. However, real-world performance data are limited, and the drug is not so acceptable to the COVID-19 patients at high risk who need it...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Min-Kyung, Lee, Kyung-Shin, Ham, Sin Young, Choi, Youn Young, Lee, Eunyoung, Lee, Seungjae, Lee, Bora, Jeon, Jaehyun, Chin, BumSik, Kim, Yeonjae, Kim, Gayeon, Jang, Hee-Chang, Choi, Jae-Phil, Park, Sang-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477076/
https://www.ncbi.nlm.nih.gov/pubmed/37667578
http://dx.doi.org/10.3346/jkms.2023.38.e272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477076/
https://www.ncbi.nlm.nih.gov/pubmed/37667578
http://dx.doi.org/10.3346/jkms.2023.38.e272

Ejemplares similares